Journals / Eastern Journal of Medicine / 2019 / Cilt: 24 - Sayı: 2

Overexpression of Insulin Receptor Substrate 1 (IRS1) Promotes Radioresistance In A172 Glioblastoma Cell Line

Pages
204–209
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Our results showed that overexpression of IRS1 led a decrease on sensitivity of the radiation in GBM cel ls.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Insulin receptor substrate 1 (IRS1) is the main adaptor molecule in insulin and insulin like growth factor signaling.
📊
Key Findings & Data:Increased level of expression of IRS1 and IGF-1R proteins are associated with many human malignancies.
💡
Conclusion & Impact:Our results showed that overexpression of IRS1 led a decrease on sensitivity of the radiation in GBM cel ls.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Insulin receptor substrate 1 (IRS1) is the main adaptor molecule in insulin and insulin like growth factor signaling. Increased level of expression of IRS1 and IGF-1R proteins are associated with many human malignancies. They also induced resistance to therapeutic approaches such as chemo- and radiotherapy in cancer treatment however their molecular mechanisms are still unclear. Glioblastoma Multiforme (GBM) is the most common primary brain tumor in adults and radiotherapy has a pivotal role in its treatment. In this study, it is aimed to determine the relationship between IRS1 expression and radiosensitivity of GBM cells. Therefore, A172 cells transfected with pcDNA3.1-HA-tagged human IRS1 gene. Its overexpression was confirmed by western blot. IRS1 overexpressed A172 cells were irradiated with 5,8 and 10 Gray ionizing radiation and their effects on cell viability determined by MTT and clonogenic assay. Our results showed that overexpression of IRS1 led a decrease on sensitivity of the radiation in GBM cel ls. As a conclusion, this study should be confirmed by further molecular analysis and in vivo studies. IRS1 may be a predictive marker of radiosensitivity for GBM.

🔖

Cite This Article

GÖRGİŞEN, G., ÇAKIR, T., ATEŞ, C., GÜLAÇAR, İ. M., YAREN, Z. (2019). Overexpression of Insulin Receptor Substrate 1 (IRS1) Promotes Radioresistance In A172 Glioblastoma Cell Line. Eastern Journal of Medicine, Cilt: 24 - Sayı: 2, 204–209. https://ajindex.com/articles/166976

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Coppola D, Ferber A, Miura M, et al. A functional insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the epidermal growth factor receptor. Mol Cell Biol 1994; 14: 4588-4595
  2. Guevara-Aguirre J, Guevara A, Palacios I, Perez M, Procel P, Teran E. GH and GHR signaling in human disease. Growth Horm IGF Res 2018; 38: 34-38
  3. Valentinis B, Morrione A, Taylor SJ, Baserga R. Insulin-like growth factor I receptor signaling in transformation by src oncogenes. Mol Cell Biol 1997; 17: 3744-3754
  4. An Y, Cai Y, Guan Y, et al. Inhibitory effect of small interfering RNA targeting insulin-like growth factor-I receptor in ovarian cancer OVCAR3 cells. Cancer Biother Radiopharm 2010; 25: 545-552
  5. Christopoulos PF, Corthay A, Koutsilieris M. Aiming for the Insulin-like Growth Factor-1 system in breast cancer therapeutics. Cancer Treat Rev 2018; 63: 79-95
  6. Kaulfuss S, Burfeind P, Gaedcke J, Scharf JG. Dual silencing of insulin-like growth factor-I receptor and epidermal growth factor receptor in colorectal cancer cells is associated with decreased proliferation and enhanced apoptosis. Mol Cancer Ther 2009; 8: 821-833
  7. Simpson A, Petnga W, Macaulay VM, WeyerCzernilofsky U, Bogenrieder T. Insulin-Like Growth Factor (IGF) Pathway Targeting in Cancer: Role of the IGF Axis and Opportunities for Future Combination Studies. Target Oncol 2017; 12: 571-597
  8. Amutha P, Rajkumar T. Role of Insulin-like Growth Factor, Insulin-like Growth Factor Receptors, and Insulin-like Growth Factorbinding Proteins in Ovarian Cancer. Indian J Med Paediatr Oncol 2017; 38: 198-206
  9. Gorgisen G, Gulacar IM, Ozes ON. The role of insulin receptor substrate (IRS) proteins in oncogenic transformation. Cell Mol Biol (Noisyle-grand) 2017; 63: 1-5
  10. Jagsi R. Progress and controversies: radiation therapy for invasive breast cancer. CA Cancer J Clin 2014; 64: 135-152
  11. Tang L, Wei F, Wu Y, et al. Role of metabolism in cancer cell radioresistance and radiosensitization methods. J Exp Clin Cancer Res 2018; 37: 87
  12. Cosaceanu D, Budiu RA, Carapancea M, Castro J, Lewensohn R, Dricu A. Ionizing radiation activates IGF-1R triggering a cytoprotective signaling by interfering with Ku-DNA binding and by modulating Ku86 expression via a p38 kinase-dependent mechanism. Oncogene 2007; 26: 2423-2434
  13. Qiu GH. Protection of the genome and central protein-coding sequences by non-coding DNA against DNA damage from radiation. Mutat Res Rev Mutat Res 2